|Bid||0.6200 x 1400|
|Ask||0.6295 x 900|
|Day's Range||0.5841 - 0.6904|
|52 Week Range||0.3280 - 1.9600|
|Beta (5Y Monthly)||3.55|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 13, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||1.83|
NEW YORK, NY / ACCESSWIRE / December 1, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies.
LOS ANGELES, CA / ACCESSWIRE / December 1, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against Zosano Pharma Corporation ("Zosano" or "the Company") (NASDAQ:ZSAN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.
New York, New York--(Newsfile Corp. - December 1, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Zosano Pharma Corporation ("Zosano") (NASDAQ: ZSAN) between February 13, 2017 and September 30, 2020. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Northern District of California. To get more ...